- FDA panel confronting peptide controversyToday's biotech news features the FDA weighing the fate of peptides; approvals for RevMed, GSK; and data on Lilly's "triple-G."STAT · 3d ago↗ source
- Merck CEO cautions Congress on imposing limits on Chinese dealmakingMerck CEO Rob Davis said he has warned Congress and the Trump administration that if they cut off or hamper US-China dealmaking, the US could lose its status as the world's biotech leader. China-…Endpoints · 3d ago↗ source
- Scancell plans Neuphoria merger; AstraZeneca wins EU nod for cancer drugScancell to merge into Neuphoria: Scancell plans to take over Neuphoria Therapeutics' Nasdaq listing {$NEUP} and change the ticker to SCLT. The company eyes up to $89 million in equity and ...